Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors
Journal of Neuroimaging · 2024-03 · 34 (2) · 257-266
DOI: 10.1111/jon.13183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroimaging, online erschienen am 03.01.2024. Verfasst von Vasco Sousa Abreu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroradiology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Lymphoma, Brain Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Background and Purpose Dynamic susceptibility contrast‐enhanced (DSC) MR perfusion is a valuable technique for distinguishing brain tumors. Diagnostic potential of measurable parameters derived from preload leakage‐corrected‐DSC‐MRI remains somewhat underexplored. This study aimed to evaluate these parameters for differentiating primary CNS lymphoma (PCNSL), glioblastoma, and metastasis.
Methods
Thirty‐nine patients with pathologically proven PCNSL ( n = 14), glioblastoma ( n = 14), and metastasis ( n = 11) were analyzed. Five DSC parameters—relative CBV (rCBV), percentage of signal recovery (PSR), downward slope (DS), upward slope (US), and first‐pass slope ratio—were derived from tumor‐enhancing areas. Diagnostic performance was assessed using receiver operating characteristic curve analysis.
Results
RCBV was higher in metastasis (4.58; interquartile range [IQR]: 2.54) and glioblastoma (3.98; IQR: 1.87), compared with PCNSL (1.46; IQR: 0.29; p = .00006 for both). rCBV better distinguished metastasis and glioblastoma from PCNSL, with an area under the curve (AUC) of 0.97 and 0.99, respectively. PSR was higher in PCNSL (88.11; IQR: 21.21) than metastases (58.30; IQR: 22.28; p = .0002), while glioblastoma (74.54; IQR: 21.23) presented almost significant trend‐level differences compared to the others ( p ≈.05). AUCs were 0.79 (PCNSL vs. glioblastoma), 0.91 (PCNSL vs. metastasis), and 0.78 (glioblastoma vs. metastasis). DS and US parameters were statistically significant between glioblastoma (−109.92; IQR: 152.71 and 59.06; IQR: 52.87) and PCNSL (−47.36; IQR: 44.30 and 21.68; IQR: 16.85), presenting AUCs of 0.86 and 0.87.
Conclusion
Metastasis and glioblastoma can be better differentiated from PCNSL through rCBV. PSR demonstrated higher differential performance compared to the other parameters and seemed useful, allowing a proper distinction among all, particularly between metastasis and glioblastoma, where rCBV failed. Finally, DS and US were only helpful in differentiating glioblastoma from PCNSL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroradiology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
ORCID-Profile: Vasco Sousa Abreu
Förderung
- None
Zitieren
APA
Abreu, V. S., Tarrio, J., Silva, J., Almeida, F., Pinto, C., Freitas, D., & Filipe, J. P. (2024). Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors. Journal of Neuroimaging, 34(2), 257-266. https://doi.org/10.1111/jon.13183
Vancouver
Abreu VS, Tarrio J, Silva J, Almeida F, Pinto C, Freitas D, et al. Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors. Journal of Neuroimaging. 2024;34(2):257-266. doi:10.1111/jon.13183
BibTeX
@article{Abreu2024,
author = {Abreu, Vasco Sousa and Tarrio, João and Silva, José and Almeida, Francisco and Pinto, Catarina and Freitas, Davide and Filipe, João Pedro},
title = {Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors},
journal = {Journal of Neuroimaging},
year = {2024},
volume = {34},
number = {2},
pages = {257--266},
doi = {10.1111/jon.13183}
}
EUVIMED